Avenue Therapeutics, Inc.
ATXI
Revenue
0.00
0.000.00%
-Assets
4.99M
▲1.68M▲50.69%
3 Months ChangeLiabilities
1.16M
▼-251.00k▼-17.78%
3 Months ChangeFree Cash Flow
0.00
0.000.00%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-27
Form 8-K
ID: 0001437749-24-030185
2024-08-09
Form 10-Q
ID: 0001437749-24-025880
2024-08-09
Form 8-K
ID: 0001437749-24-025872
2024-06-26
Form 8-K
ID: 0001437749-24-021302
2024-05-23
Form 8-K
ID: 0001437749-24-018072
2024-05-15
Form 10-Q
ID: 0001437749-24-017062
2024-05-15
Form 8-K
ID: 0001437749-24-016818
2024-05-13
Form 8-K
ID: 0001437749-24-016081
2024-05-01
Form 8-K
ID: 0001437749-24-014178
2024-04-26
Form 8-K
ID: 0001437749-24-013436